Genmab A/S (GMAB)
50.81
-0.93
(-1.80%)
USD |
NASDAQ |
Nov 13, 10:51
Genmab Market Cap : 31.25B for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 31.82B |
| November 11, 2026 | 33.13B |
| November 10, 2026 | 33.25B |
| November 09, 2026 | 34.31B |
| November 06, 2026 | 32.98B |
| November 05, 2026 | 32.43B |
| November 04, 2026 | 33.90B |
| November 03, 2026 | 34.14B |
| November 02, 2026 | 32.79B |
| October 30, 2026 | 34.07B |
| October 29, 2026 | 33.73B |
| October 28, 2026 | 34.20B |
| October 27, 2026 | 26.67B |
| October 26, 2026 | 26.68B |
| October 23, 2026 | 26.14B |
| October 22, 2026 | 23.88B |
| October 21, 2026 | 23.62B |
| October 20, 2026 | 23.33B |
| October 19, 2026 | 22.99B |
| October 16, 2026 | 22.09B |
| October 15, 2026 | 22.58B |
| October 14, 2026 | 22.02B |
| October 13, 2026 | 21.83B |
| October 12, 2026 | 22.31B |
| October 09, 2026 | 22.13B |
| Date | Value |
|---|---|
| October 08, 2026 | 21.52B |
| October 07, 2026 | 21.88B |
| October 06, 2026 | 22.57B |
| October 05, 2026 | 22.97B |
| October 02, 2026 | 20.75B |
| October 01, 2026 | 20.63B |
| September 30, 2026 | 21.30B |
| September 29, 2026 | 21.24B |
| September 28, 2026 | 21.11B |
| September 25, 2026 | 21.09B |
| September 24, 2026 | 20.79B |
| September 23, 2026 | 20.75B |
| September 22, 2026 | 21.03B |
| September 21, 2026 | 20.71B |
| September 18, 2026 | 20.74B |
| September 17, 2026 | 20.62B |
| September 16, 2026 | 20.54B |
| September 15, 2026 | 20.39B |
| September 14, 2026 | 19.49B |
| September 11, 2026 | 19.39B |
| September 10, 2026 | 19.24B |
| September 09, 2026 | 19.73B |
| September 08, 2026 | 20.02B |
| September 04, 2026 | 20.06B |
| September 03, 2026 | 20.54B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AbbVie, Inc. | 522.65B |
| Incyte Corp. | 24.52B |
| Ascendis Pharma A/S | 17.97B |
| Zealand Pharma A/S | 2.478B |
| Novo Nordisk A/S | 137.21B |
Market Cap Related Metrics
| PE Ratio | 43.53 |
| PS Ratio | 7.547 |
| Price to Book Value | 4.934 |
| Price to Free Cash Flow | 38.45 |
| Price | 50.81 |
| Earnings Yield | 2.30% |
| Operating PE Ratio | 24.64 |
| Normalized PE Ratio | 34.88 |